
AgomAb Therapeutics N.V. American Depositary Shares
AGMBHealthcare|Biotechnology|BE
$7.63
+0.67 (+9.54%)
DCF Value
$1.89
Tangible Book / Share
$4.86
Cash / Share
$5.17
Ownership Breakdown
74.0%
Float
49.2M
Shares Outstanding
36.5M
Float Shares
Major Holders (14)
Combined: 100.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| LSP 7 Cooperatieve U.A. | Other | 10.60% | 5,141,992 | Feb 17, 2026 | 13D/G |
| LSP 7 Management B.V. | Other | 10.60% | 5,141,992 | Feb 17, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 10.00% | 4,873,680 | Mar 6, 2026 | 13D/G |
| FMR LLC | Holding company | 10.00% | 4,873,680 | Mar 6, 2026 | 13D/G |
| Pontifax Management 4 G.P. (2015) Ltd. | Corporation | 6.80% | 3,305,846 | Apr 16, 2026 | 13D/G |
| Tomer Kariv | Individual | 6.80% | 3,305,846 | Apr 16, 2026 | 13D/G |
| Pontifax VI G.P. L.P. | Partnership | 6.80% | 3,305,846 | Apr 16, 2026 | 13D/G |
| Ran Nussbaum | Individual | 6.80% | 3,305,846 | Apr 16, 2026 | 13D/G |
| Sanofi | Corporation | 5.71% | 2,783,096 | May 6, 2026 | 13D/G |
| Redmile Group, LLC | IA, OO | 5.60% | 2,735,926 | May 15, 2026 | 13D/G |
| Jeremy C. Green | HC, IN | 5.60% | 2,735,926 | May 15, 2026 | 13D/G |
| Redmile Biopharma Investments III, L.P. | Partnership | 5.60% | 2,735,926 | May 15, 2026 | 13D/G |
| Cormorant Asset Management, LP | IA, PN | 5.01% | 2,465,348 | May 15, 2026 | 13D/G |
| Bihua Chen | HC, IN | 5.01% | 2,465,348 | May 15, 2026 | 13D/G |
Insider Trades (17)
Last 4 quarters: 174,810 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Epstein David R | director | Nov 5, 2026 | BUY | 5,000 | $6.98 | $34.9K | Form 4 |
| Epstein David R | director | Nov 5, 2026 | BUY | 5,000 | $6.91 | $34.5K | Form 4 |
| Epstein David R | director | Nov 5, 2026 | BUY | 5,000 | $6.81 | $34.0K | Form 4 |
| Epstein David R | director | Oct 21, 2026 | BUY | 5,000 | $8.90 | $44.5K | Form 4 |
| Epstein David R | director | Oct 21, 2026 | BUY | 5,000 | $8.86 | $44.3K | Form 4 |
| Epstein David R | director | Oct 8, 2026 | BUY | 5,000 | $8.90 | $44.5K | Form 4 |
| Epstein David R | director | Oct 6, 2026 | BUY | 5,000 | $8.70 | $43.5K | Form 4 |
| Epstein David R | director | Oct 5, 2026 | BUY | 5,000 | $8.57 | $42.9K | Form 4 |
| Kemula Pierre Thadee Victor | Chief Financial Officer | Oct 6, 2026 | BUY | 2,000 | $8.54 | $17.1K | Form 4 |
| Kemula Pierre Thadee Victor | Chief Financial Officer | Oct 6, 2026 | BUY | 5,000 | $8.57 | $42.9K | Form 4 |
| Kemula Pierre Thadee Victor | Chief Financial Officer | Oct 6, 2026 | BUY | 3,000 | $8.67 | $26.0K | Form 4 |
| Knotnerus Tim Jasper | director, officer: Chief Executive Officer | Oct 6, 2026 | BUY | 5,000 | $8.70 | $43.5K | Form 4 |
| Knotnerus Tim Jasper | director, officer: Chief Executive Officer | Oct 5, 2026 | BUY | 6,000 | $8.48 | $50.9K | Form 4 |
| Garcia Marino | director | Sep 11, 2026 | AWARD | 57,482 | $13.94 | $801.3K | Form 4 |
| Patel Naimish | director | Sep 11, 2026 | AWARD | 56,328 | $13.94 | $785.2K | Form 4 |
| Garcia Marino | director: | Sep 11, 2026 | OTHER | 0 | — | — | Form 4 |
| Patel Naimish | director: | Sep 11, 2026 | OTHER | 0 | — | — | Form 4 |